Bibliography

Export 273 results:

Filters: Keyword is Transplantation, Homologous [Clear All Filters]

1975

Penn I. Immunosuppression and cancer. Importance in head and neck surgery. Arch Otolaryngol. 1975;101(11):667-70.

Penn I. The incidence of malignancies in transplant recipients. Transplant Proc. 1975;7(2):323-6.

Penn I. Malignant disease in immunodeficient states in man. Recent Results Cancer Res. 1975;(52):96-106.

Doig RL, Boyd PJ, Eykyn S. Staphylococcus aureus transmitted in transplanted kidneys. Lancet. 1975;2(7928):243-5.

Sharpe DN, Singh BN, Cornere BM, Allwood GK. Torulopsis glabrata endocarditis complicating aortic homograft valve treated with 5-fluorocytosine: case report with discussion of antifungal chemotherapy. The New Zealand medical journal//N Z Med J. 1975;81(536):294-8.

1974

Penn I. Chemical immunosuppression and human cancer. Cancer. 1974;34(4 Suppl):suppl:1474-80.

Koranda FC, Dehmel EM, Kahn G, Penn I. Cutaneous complications in immunosuppressed renal homograft recipients. Jama. 1974;229(4):419-24.

Starzl TE, Porter KA, Halgrimson CG, Husberg BS, Penn I, Putnam CW. A decade followup in early cases of renal homotransplantation. Ann Surg. 1974;180(4):606-16.

Husberg B, Penn I, Freedman HH. Evaluation of oxisuran as an immunosuppressive agent. Proc Soc Exp Biol Med. 1974;145(2):669-74.

Penn I. Occurrence of cancer in immune deficiencies. Cancer. 1974;34(3):suppl:858-66.

1973

Starzl TE, Groth CG, Putnam CW, Corman J, Halgrimson CG, Penn I, et al. Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc. 1973;5(1):511-6.

Gustafsson A, Groth CG, Halgrimson CG, Penn I, Starzl TE. The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet. 1973;137(1):40-2.

Penn I, Starzl TE. Immunosuppression and cancer. Transplant Proc. 1973;5(1):943-7.

Penn I. Transplantation of kidneys containing primary malignant tumors. Transplantation. 1973;16(6):674-5.

Lakshiminarayan S, Sahn SA. Tuberculosis in a patient after renal transplantation. Tubercle. 1973;54(1):72-6.

Corman JL, Kashiwagi N, Porter KA, Andres G, Iwatsuki S, Putnam CW, et al. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation. 1973;16(1):60-3.

1972

Penn I, Durst AL, Machado M, Halgrimson CG, S., Bynon J. J, Putman CW, et al. Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg. 1972;105(2):167-72.

Starzl TE, Groth CG, Kashiwagi N, Putnam CW, Corman JL, Halgrimson CG, et al. Clinical experience with horse antihuman ALG. Transplant Proc. 1972;4(4):491-5.

Martineau G, Porter KA, Corman J, Launois B, Schroter GT, Palmer W, et al. Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery. 1972;72(4):604-10.

Anthony CW. Disseminated toxoplasmosis in a liver transplant patient. J Am Med Womens Assoc. 1972;27(11):601-3.

Andres GA, Ansell ID, Halgrimson CG, Hsu KC, Porter KA, Starzl TE, et al. Immunopathological studies of orthotopic human liver allografts. Lancet. 1972;1(7745):275-80.

Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL, et al. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet. 1972;1(7764):1310-3.

Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation. 1972;14(4):407-17.

Starzl TE, Corman J, Groth CG, Halgrimson CG, Penn I, Putnam CW, et al. Personal experience with orthotopic liver transplantation. Transplant Proc. 1972;4(4):759-71.

Penn I, Starzl TE. Proceedings: The effect of immunosuppression on cancer. Proc Natl Cancer Conf. 1972;7:425-36.

Pages